Neuren Pharmaceuticals Limited logo

Neuren Pharmaceuticals Limited (NURPF)

Market Closed
12 Jun, 20:00
OTC PINK OTC PINK
$
8. 88
0
0%
$
1.12B Market Cap
- P/E Ratio
- Div Yield
250 Volume
- Eps
$ 8.88
Previous Close
Add Transaction
Day Range
8.88 8.88
Year Range
7.7 14.8
Want to track NURPF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Neuren Pharmaceuticals Limited (NURPF) Statistics

Valuation metrics

Market Cap 1.12B
Enterprise value 1.69B
Trailing P/E (ttm) 55.71
Forward P/E -
PEG ratio -0.71
Price/Sales (ttm) 26.17
Price/Book (mrq) 5.01
Enterprise Value/Revenue 26.1
Enterprise Value/EBITDA 76.53

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 31
Average volume (90 days) 109

Price summary

52-Week low 7.7
52-Week high 14.8
Beta -
50-Day moving average 8.86
200-Day moving average 10.17

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:20
Last split Date 21 Nov 2017

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin 0.47%
Operating margin 0.11%

Operational effectiveness

Return on assets 0.09%
Return on equity 0.09%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) 0.51
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 0.24
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 2.34
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 76.6%
Book value per share (mrq) 2.67

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -